CVLB News and Press, Conversion Labs Inc

The following slide deck was published by Conversion Labs, Inc. in conjunction with this event. For further details see: Conversion Labs (CVLB) Investor Presentation - Slideshow

NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-patient telehealth company, has been invited to present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held on February 17...

Direct-to-patient telehealth company Conversion Labs ([[CVLB]] +7.2%) said that it will change its name to Life MD later this month, followed by the official launch of its subscription-based primary care and concierge services offering.Upon the name change, the company expects its s...

NEW YORK, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a leading direct-to-patient telehealth company, will change its name to Life MD™ on February 22, followed by the official launch of its subscription-based primary care and concierge ser...

Conversion Labs was highlighted in a bull call by Citron Research. The company is building a DTC health and wellness platform focused on subscription services. Q4 revenues surged 265% to $13.6 million. The stock is cheap compared to other telehealth brands trading at less than...

Conversion Labs (CVLB) rallied 8.7% in premarket trade after appointing 18-years industry veteran Marc Benathen as CFO, effective Mar.1, succeeding Juan Manuel Piñeiro Dagnery, who will continue as chief revenue officer.Benathen brings to the company experience in tea...

NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has appointed Marc Benathen as chief financial officer, effective March 1. He succeeds Juan Manuel Piñeiro Dagnery, who will continu...

Conversion Labs (CVLB) jumping 14% after Citron Research tweeted about the company, comparing its business to Hims & Hears Health (HIMS), which is rising 16% today after being removed from Robinhood restricted list.Conversion Labs would be valued at $140 (trading at ~$24 now) at...

Gainers: Lianluo Smart (LLIT) +101%, Sundial Growers (SNDL) +51%, Monopar Therapeutics (MNPR) +38%, Regional Health Properties (RHE) +20%, Conversion Labs (CVLB) +18%.Losers: Vir Biotechnology (VIR) -31%, Zymeworks ZYME -25%, American Well (AMWL) -...

NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has increased its stake in its legacy LegalSimpli Software subsidiary from 51% to 82.6%, largely from the conversion of long-term debt held b...